Literature DB >> 10887506

TGF-beta in mammary development and neoplasia.

C L Arteaga1, H L Moses.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 10887506     DOI： 10.1007/BF02017388

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN： 1083-3021            Impact factor:   2.673


× No keyword cloud information.
  16 in total

1.  Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

Authors:  H Y Lin; X F Wang; E Ng-Eaton; R A Weinberg; H F Lodish
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.

Authors:  F López-Casillas; S Cheifetz; J Doody; J L Andres; W S Lane; J Massagué
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

Review 3.  Transforming growth factors and the regulation of cell proliferation.

Authors:  R M Lyons; H L Moses
Journal:  Eur J Biochem       Date:  1990-02-14

Review 4.  The cell biology of transforming growth factor beta.

Authors:  J A Barnard; R M Lyons; H L Moses
Journal:  Biochim Biophys Acta       Date:  1990-06-01

5.  Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.

Authors:  G D Shipley; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

7.  TGF beta signals through a heteromeric protein kinase receptor complex.

Authors:  J L Wrana; L Attisano; J Cárcamo; A Zentella; J Doody; M Laiho; X F Wang; J Massagué
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

8.  The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand.

Authors:  A Moustakas; H Y Lin; Y I Henis; J Plamondon; M D O'Connor-McCourt; H F Lodish
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.

Authors:  R Ebner; R H Chen; S Lawler; T Zioncheck; R Derynck
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

10.  Characterization of type I receptors for transforming growth factor-beta and activin.

Authors:  P ten Dijke; H Yamashita; H Ichijo; P Franzén; M Laiho; K Miyazono; C H Heldin
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728
View more
  2 in total

Review 1.  Animal models of breast cancer for the study of pathogenesis and therapeutic insights.

Authors:  Angels Sierra
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

2.  Clinical Implications of TβRII Expression in Breast Cancer.

Authors:  Ningning Gao; Qixi Zhai; Yinyan Li; Kun Huang; Donglin Bian; Xuemei Wang; Caigang Liu; Hong Xu; Teng Zhang
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.